HC Wainwright & Co. Maintains Buy on Yield10 Bioscience, Lowers Price Target to $4
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Amit Dayal maintains a 'Buy' rating on Yield10 Bioscience (NASDAQ:YTEN) but has lowered the price target from $25 to $4.
August 17, 2023 | 10:16 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Despite the lowered price target from $25 to $4, HC Wainwright & Co. maintains a 'Buy' rating on Yield10 Bioscience.
The significant reduction in the price target for Yield10 Bioscience by HC Wainwright & Co. could negatively impact the stock's price in the short term. However, the maintained 'Buy' rating indicates the analyst's continued confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100